Historically, the main target of therapy in inflammatory bowel disease (IBD) has been to achieve and maintain clinical remission. By achieving this goal, we had hoped improve our patients' health-related quality life (QoL) avoid disease-related complications including hospitalizations surgeries. However, while patients value functional improvement that occurs with remission, targeting remission...